BPC 157 5mg + TB500 5mg
A research-use combined recovery peptide entry for product verification and clinician-guided safety review.
Contents
Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.
Quickstart Highlights
TB-500 & BPC-157 dosage protocol combines two research peptides often used together for synergistic tissue repair and recovery.
- TB-500 (5 mg/week standard) injected once or twice weekly
- BPC-157 ~500 mcg/day (can be split into 1–2 daily doses)
- Recommended 4–6 week cycle or longer, based on research needs
- Reconstitute each vial with bacteriostatic water up to 3 mL
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
| Week | Daily Total (mcg) | Per Injection | Units (mL) | Frequency |
|---|---|---|---|---|
| Weeks 1–2 | 750 mcg/day | ~375 mcg | ~7.5 units (0.075 mL) | 2× per day |
| Weeks 3–4 | 500 mcg/day | 500 mcg | ~10 units (0.1 mL) | 1× per day |
- Reconstitute with 2 mL of bacteriostatic water to achieve a concentration of 2.5 mg/mL. Each full vial = 5 mg total.
- This approach splits the 5 mg weekly dose into two subcutaneous injections. At 2.5 mg per injection, you’ll draw about 1 mL (100 units) if reconstituted to 2 mL total.
- Draw 2.0 mL of bacteriostatic water into a sterile syringe.
- Inject slowly along the vial wall to minimize foam.
- Gently swirl the vial—avoid vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
- Gradually taper from 2 smaller doses to a single daily dose if desired. With 2 mL total volume, 1 mg is ~0.4 mL (40 units). Typical ~500 mcg/day usage remains easy to measure above 10 units.
- Reconstitute with 1 mL of bacteriostatic water for a 5 mg/mL solution.
- An advanced protocol may push to 10 mg weekly by administering 5 mg twice per week. Mixing with just 1 mL of water yields ~5 mg per 1 mL (100 units). If 5 mg in a single injection feels too high, split it into smaller doses.
- Draw 1.0 mL of bacteriostatic water into a sterile syringe.
- Inject slowly along the vial wall.
- Gently swirl—avoid vigorous shaking.
- Reconstitute with 2 mL of bacteriostatic water, resulting in 2.5 mg/mL. Ideal for daily or split-daily injections.
- Inject along the vial wall slowly to reduce foaming.
- Gently swirl—avoid shaking vigorously.
- Reconstitute with 1 mL of bacteriostatic water for a 5 mg/mL concentration.
- Smaller injection volumes can be harder to measure. If going below ~10 units, consider using a 50-unit or 30-unit syringe for better accuracy.
- Inject slowly; gently swirl until dissolved.
- You can run both peptides simultaneously:
- TB-500: 5–10 mg weekly (1–2 injections each week)
- BPC-157: ~500 mcg/day, or an advanced protocol up to ~750 mcg/day
- Each peptide reconstituted in its own vial; do not mix in the same syringe
- Users often report synergistic recovery effects with both peptides. Administering them on the same day is fine; just use separate syringes and injection sites if desired.
Supplies Needed
Basic materials for a 4–6 week cycle.
- Peptide Vials:• TB-500 (5 mg Vial)• BPC-157 (5 mg Vial)(Adjust based on total duration)
- Insulin Syringes: 1 per injection (30–100 unit size)
- Bacteriostatic Water: 1× 30 ml or as needed
- Alcohol Swabs: 1 box
Protocol Overview
A concise weekly (TB-500) and daily (BPC-157) injection strategy.
Dosing Protocol
Recommended approach for combining both peptides effectively.
- Injection Method: Subcutaneous, rotating sites
- TB-500 Schedule: Typically 2 injections per week (e.g., Monday & Thursday)
- BPC-157 Schedule: Daily or split daily for Weeks 1–4, optional taper afterward
- Timing: Separate syringes; no need for precise timing alignment
- Duration: 4+ weeks, re-assess based on progress
Storage Instructions
Proper handling preserves peptide quality.
- Lyophilized: Keep frozen until ready to mix
- Reconstituted: Store at 2–8°C; use within 30 days
- Protect from light; keep vials upright if possible
- Avoid repeated freeze-thaw cycles
Important Notes
Tips for safe, consistent usage.
- Use new, sterile insulin syringes every time; rotate injection sites.
- Maintain consistent protocol; peptides often show best results with regular use.
- Monitor for adverse reactions; consult a professional if needed.
- Do not mix TB-500 and BPC-157 in the same syringe.
How This Works
Both peptides are known for supporting tissue repair in various research settings.
Potential Benefits & Side Effects
Research suggests various therapeutic benefits, with some caution advised.
Injection Technique
Simple guidelines for safe daily injections.
- Clean vial rubber stopper & injection site with alcohol swabs
- Insert needle at a 45–90° angle into subcutaneous tissue
- Inject slowly & rotate sites (abdomen, thigh, etc.)
Lifestyle Factors
Simple habits can complement peptide usage.
- Adopt a balanced, protein-rich diet
- Engage in regular exercise; allow sufficient recovery
- Focus on stress management and adequate sleep
Recommended Source
We recommend Pure Lab Peptides for high-purity BPC-157 + TB-500 blend.
- Verifies ≥99% purity through independent lab testing
- Trusted by researchers seeking reliable results
- Follows rigorous manufacturing standards for consistent quality
- Shop at Pure Lab Peptides
Important Note
This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.
- Do not start, stop, combine, or change a protocol based only on website content.
- Emergency symptoms require urgent medical care, not a website or routine follow-up message.
References
– PatientPop PDF (Obesity / AOD-9604 Study)
- TB-500 (5mg Vial) & BPC-157 (5mg Vial) Open source
- Frontiers in Endocrinology (2021) — Progress on the Function and Application of Thymosin β4 View Source Open source
- Annals of the New York Academy of Sciences — Thymosin β4: roles in development, repair, and engineering of the cardiovascular system View Source Open source
- Frontiers in Pharmacology (2022) — Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 View Source Open source
- HSS Journal (2025) — Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review View Source Open source
- Current Pharmaceutical Design (2018) — Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract View Source Open source
- Journal of Orthopaedic Surgery and Research (2019) — BPC 157 and its effects on tendon healing View Source Open source
- CDC (2024) — Vaccine Administration: Subcutaneous (SUBCUT) Injection View Source Open source
- NCBI Bookshelf (2023) — Administration of Parenteral Medications – Nursing Skills View Source Open source
- CDC (NCHS) — Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) View Source Open source
- CDC (2023) — General Best Practice Guidelines for Immunization: Vaccine Administration View Source Open source
- Pure Lab Peptides — TB-500 (5 mg) product page View Source Open source
- Pure Lab Peptides — BPC-157 (5 mg) product page View Source Open source